Skip to main content
ARQT logo
ARQT
(NASDAQ)
Arcutis Biotherapeutics, Inc.
$25.14-- (--)
Loading... - Market loading

Arcutis Biotherapeutics (ARQT) Stock Price & Financial Analysis

Arcutis Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$24.45 - $25.50
52-Week High$31.77
52-Week Low$15.10
Open$24.85
Volume1.41M
Average Volume (3M)1.56M
Market Cap3.25B
Shares Outstanding129.37M
Price to Sales (P/S)7.82
Price to Book (P/B)17.15
EV/EBITDA249.82
Revenue (TTM)415.62M
Net Income (TTM)-2.38M
Free Cash Flow (TTM)26.92M
EPS (TTM)$-0.02
Profit Margin-0.57%
Operating Margin0.77%
Return on Equity (ROE)-1.25%
Debt to Equity0.07
50-Day MA$26.73
200-Day MA$25.61
52-Week Change58.44%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arcutis Biotherapeutics

What is the current stock price for ARQT?

As of the latest trading session, ARQT stock trades at $25.14. The 52-week range is $15.10–$31.77, with a day range of $24.45–$25.50.

What is the P/E ratio for ARQT?

The P/E ratio (Price-to-Earnings) for ARQT is shown in the Key Statistics section. This valuation metric helps compare Arcutis Biotherapeutics, Inc. to industry peers.

Does ARQT pay dividends?

Arcutis Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARQT?

Based on 3 analysts, the consensus for ARQT is Buy.

What is the market cap of ARQT?

Arcutis Biotherapeutics's market capitalization is $3.25B, classifying it as a mid-cap company. Arcutis Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.